FDA Adverse Event Malfunction Summary report: N

HOMECHOICE PRO

MDR report key: 3022275 · Received March 27, 2013

Report

Report Number
1416980-2013-07350
Event Type
Malfunction
Date Received
March 27, 2013
Date of Event
February 20, 2013
Report Date
March 1, 2013
Manufacturer
BAXTER HEALTHCARE - LARGO
Product Code
FKX
Removal / Correction Number
1423500-01/08/10-001-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: THE DEVICE WAS RETURNED TO BAXTER AND THE EVALUATION IS COMPLETE. THIS CONDITION IS AN ANCILLARY SERVICE EVENT. THE REPORTED DIFFICULTY OF AN IIPV EVENT WAS CONFIRMED THROUGH AN EVENT HISTORY LOG REVIEW. THE CAUSE WAS A USE ERROR, AS THE TIDAL TOTAL ULTRA-FILTRATION REMOVAL WAS SET TOO LOW. ADDITIONAL INFORMATION: HOMECHOICE AND HOMECHOICE PRO APD SYSTEMS PATIENT AT-HOME GUIDE. SECTION 9 "OPERATING INSTRUCTIONS - CHANGE PROGRAM" STATES THIS WARNING IN TABLE 9-7 ON PAGE 9-21 "A TOTAL UF VOLUME SET TOO LOW CAN RESULT IN A GRADUAL BUILDUP OF UF VOLUME DURING THE THERAPY. THIS CAN RESULT IN AN INCREASED INTRAPERITONEAL VOLUME (IIPV) SITUATION." PAGE 9-22 STATES "SEVENTY PERCENT (70%) OF YOUR NORMAL NIGHT UF IS A GOOD STARTING POINT FOR DETERMINING YOUR OPTIMUM TOTAL UF." IF ANY ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A FOLLOW-UP WILL BE SENT.

Description of Event or Problem · 1

DURING EVALUATION OF A RETURNED HOMECHOICE MACHINE, ONE INCREASED INTRA-PERITONEAL VOLUME (IIPV) EVENT WAS IDENTIFIED. THIS OCCURRED IN THERAPY DURING NIGHT DRAIN CYCLE EIGHT. THE PATIENT'S ULTRAFILTRATION READING WAS 2160ML, WHICH INDICATES THAT THE HOME PATIENT (HP) DRAINED 1460ML MORE THAN THEIR MAXIMUM PROGRAMMED FILL VOLUME OF 2000ML. THIS INFORMATION MEETS IIPV CRITERIA. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
126780 HOMECHOICE PRO SYSTEM, PERITONEAL, AUTOMATIC DELIVERY FKX BAXTER HEALTHCARE - LARGO

Patients

Seq Age Sex Outcome Treatment
1